Literature DB >> 16540107

Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.

Stuart A Dunbar1, Ivan Karamian, Amy Yeatman, Jiahui Zhang.   

Abstract

Chronic opioid administration is associated with altered nociception. The mechanisms underlying these changes are not fully understood. Nociceptive transmission within the spinal cord is modulated by both excitatory and inhibitory neurotransmitters. Using spinal microdialysis, the effects of recurrent withdrawal on the release of gamma-aminobutyric acid (GABA), at rest or after naloxone stimulation, was investigated in rats chronically exposed to morphine. For comparison purpose, the release of glutamate was investigated in parallel. We observed that chronic morphine treatment alone significantly inhibited resting GABA release; and recurrent withdrawal appeared to reverse this effect. Recurrent withdrawal also significantly elevated resting glutamate levels. In addition, we observed that only acute withdrawal moderately increased stimulated GABA release. In contrast, both acute and recurrent withdrawal markedly increased stimulated glutamate release. These observed changes in GABA release offer direct evidence that GABA may contribute to the altered nociceptive response mediated by opioids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540107     DOI: 10.1016/j.ejphar.2006.02.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 3.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

4.  The Role of GABAB Receptors in Morphine Self-Administration.

Authors:  Effat Ramshini; Hojjatallah Alaei; Parham Reisi; Samaneh Alaei; Somaye Shahidani
Journal:  Int J Prev Med       Date:  2013-02

5.  Molecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic pain.

Authors:  Karine Thibault; Bernard Calvino; Isabelle Rivals; Fabien Marchand; Sophie Dubacq; Stephen B McMahon; Sophie Pezet
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

6.  KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia.

Authors:  Yuan Gao; Wenqiang Zhan; Yushi Jin; Xiaodan Chen; Jinxia Cai; Xiaotian Zhou; Xinyi Huang; Qimin Zhao; Weijian Wang; Jiehao Sun
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.395

7.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.